GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
Source | Last Updated |
---|---|
GlycoNAVI Proteins | December 11, 2024 |
PDB ID | UniProt ID ▼ | Title | Descriptor |
---|---|---|---|
7A94 | P0DTC2 | SARS-CoV-2 Spike Glycoprotein with 1 ACE2 Bound | |
7B62 | P0DTC2 | Crystal structure of SARS-CoV-2 spike protein N-terminal domain in complex with biliverdin | |
7BEO | P0DTC2 | Crystal structure of the receptor binding domain of SARS-CoV-2 Spike glycoprotein in a ternary complex with COVOX-253H55L and COVOX-75 Fabs | |
7CHO | P0DTC2 | Crystal structure of SARS-CoV-2 antibody P5A-1D2 with RBD | |
7CT5 | P0DTC2 | S protein of SARS-CoV-2 in complex bound with T-ACE2 | |
7DWZ | P0DTC2 | S protein of SARS-CoV-2 in the active conformation | |
7DX8 | P0DTC2 | Trypsin-digested S protein of SARS-CoV-2 bound with PD of ACE2 in the conformation 2 (2 up RBD and 2 PD bound) | |
7E3J | P0DTC2 | Crystal structure of SARS-CoV-2 RBD binding to dog ACE2 | |
7E7B | P0DTC2 | Cryo-EM structure of the SARS-CoV-2 furin site mutant S-Trimer from a subunit vaccine candidate | |
7E8M | P0DTC2 | Crystal structure of SARS-CoV-2 antibody P2C-1F11 with mutated RBD | |
7EJ4 | P0DTC2 | Cryo-EM structure of SARS-CoV-2 spike in complex with a neutralizing antibody RBD-chAb-25 | |
7KL9 | P0DTC2 | Structure of the SARS-CoV-2 S 6P trimer in complex with the ACE2 protein decoy, CTC-445.2 (State 4) | |
7LRT | P0DTC2 | Cryo-EM structure of SARS-CoV-2 spike in complex with neutralizing antibody A23-58.1 that targets the receptor-binding domain | |
7LWK | P0DTC2 | Mink Cluster 5-associated SARS-CoV-2 spike protein (S-GSAS-D614G-delFV) in the 3-RBD down conformation | |
7LWQ | P0DTC2 | Mink Cluster 5-associated SARS-CoV-2 spike protein(S-GSAS-D614G-delFV) missing the S1 subunit and SD2 subdomain of one protomer | |
7LWW | P0DTC2 | Triple mutant (K417N-E484K-N501Y) SARS-CoV-2 spike protein in the 1-RBD-up conformation (S-GSAS-D614G-K417N-E484K-N501Y) | |
7LY2 | P0DTC2 | SARS-CoV-2 S/S2M11/S2M28 Global Refinement | |
7MM0 | P0DTC2 | Cryo-EM structure of SARS-CoV-2 spike in complex with neutralizing antibody B1-182.1 that targets the receptor-binding domain | |
7MTD | P0DTC2 | Structure of aged SARS-CoV-2 S2P spike at pH 7.4 | |
7MY3 | P0DTC2 | CryoEM structure of neutralizing nanobody Nb12 in complex with SARS-CoV2 spike | |
6LZG | P0DTC2 | Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2 | |
6M0J | P0DTC2 | Crystal structure of SARS-CoV-2 spike receptor-binding domain bound with ACE2 | |
6VXX | P0DTC2 | Structure of the SARS-CoV-2 spike glycoprotein (closed state) | |
6W41 | P0DTC2 | Crystal structure of SARS-CoV-2 receptor binding domain in complex with human antibody CR3022 | |
6WPS | P0DTC2 | Structure of the SARS-CoV-2 spike glycoprotein in complex with the S309 neutralizing antibody Fab fragment | |
6WPS | P0DTC2 | Structure of the SARS-CoV-2 spike glycoprotein in complex with the S309 neutralizing antibody Fab fragment | |
6XC2 | P0DTC2 | Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody CC12.1 | |
6XC4 | P0DTC2 | Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody CC12.3 | |
6XC7 | P0DTC2 | Crystal structure of SARS-CoV-2 receptor binding domain in complex with antibodies CC12.3 and CR3022 | |
6ZOZ | P0DTC2 | Structure of Disulphide-stabilized SARS-CoV-2 Spike Protein Trimer (x1 disulphide-bond mutant, S383C, D985C, K986P, V987P, single Arg S1/S2 cleavage site) in Locked State | |
6ZWV | P0DTC2 | Cryo-EM structure of SARS-CoV-2 Spike Proteins on intact virions: 3 Closed RBDs | |
7A5R | P0DTC2 | Complex of SARS-CoV-2 spike and CR3022 Fab (Non-Uniform Refinement) | |
7AKD | P0DTC2 | Structure of the SARS-CoV-2 spike glycoprotein in complex with the 47D11 neutralizing antibody Fab fragment | |
7BEI | P0DTC2 | Crystal structure of the receptor binding domain of SARS-CoV-2 Spike glycoprotein in complex with COVOX-150 Fab | |
7BEJ | P0DTC2 | Crystal structure of the receptor binding domain of SARS-CoV-2 Spike glycoprotein in complex with COVOX-158 Fab (crystal form 1) | |
7BEN | P0DTC2 | Crystal structure of the receptor binding domain of SARS-CoV-2 Spike glycoprotein in a ternary complex with COVOX-253 and COVOX-75 Fabs | |
7BNO | P0DTC2 | Open conformation of D614G SARS-CoV-2 spike with 2 Erect RBDs | |
7BWJ | P0DTC2 | crystal structure of SARS-CoV-2 antibody with RBD | |
7CAB | P0DTC2 | Structural basis for neutralization of SARS-CoV-2 and SARS-CoV by a potent therapeutic antibody | |
7CHH | P0DTC2 | Cryo-EM structure of the SARS-CoV-2 S-6P in complex with BD-368-2 Fabs | |
7CM4 | P0DTC2 | Crystal Structure of COVID-19 virus spike receptor-binding domain complexed with a neutralizing antibody CT-P59 | |
7D00 | P0DTC2 | S protein of SARS-CoV-2 in complex bound with FabP5A-1B8 | |
7DF3 | P0DTC2 | SARS-CoV-2 S trimer, S-closed | |
7DF4 | P0DTC2 | SARS-CoV-2 S-ACE2 complex | |
7DK0 | P0DTC2 | Crystal structure of SARS-CoV-2 Spike RBD in complex with MW05 Fab | |
7DX2 | P0DTC2 | Trypsin-digested S protein of SARS-CoV-2 D614G mutant | |
7E7D | P0DTC2 | Cryo-EM structure of the SARS-CoV-2 wild-type S-Trimer from a subunit vaccine candidate | |
7EAZ | P0DTC2 | Cryo-EM structure of SARS-CoV-2 Spike D614G variant, one RBD-up conformation 1 | |
7EDF | P0DTC2 | Cryo-EM structure of SARS-CoV-2 S-UK variant (B.1.1.7), one RBD-up conformation 1 | |
7EDJ | P0DTC2 | Cryo-EM structure of SARS-CoV-2 S-UK variant (B.1.1.7) in complex with Angiotensin-converting enzyme 2 (ACE2) ectodomain |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.1.0
Last updated: December 9, 2024